Method for extracting a macrolide from biomatter
AssigneeTEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság
InventorsVilmos Keri, Janos Rako, Ferenc Rantal, Andrea Csorvasi
Life of this patent
Estimating the term…
Abstract
Provided is a method for obtaining a macrolide, especially tacrolimus, ascomycin, pimecrolimus, sirolimus, or everolimus, from biomatter.
Claims43
A method for obtaining a macrolide selected from the group consisting of tacrolimus, ascomycin, pimecrolimus, sirolimus, and everolimus comprising the step of extracting macrolide-containing biomatter that is whole fermentation broth with a hydrophobic extraction solvent to obtain a solution of the macrolide in the hydrophobic extraction solvent, wherein the pH of the macrolide-containing biomatter being extracted is between 8 and about 13 and recovering said macrolide from said solution, wherein the macrolide-containing biomaffer is tacrolimus-containing biomatter when tacrolimus is to be obtained, ascomycin-containing biomatter when ascomycin is to be obtained, pimecrolimus-containing biomatter when primecrolimus is to be obtained, sirolimus-containing biomatter when sirolimus is to be obtained, and everolimus-contaming biomatter when everolimus is to be obtained.
A method for obtaining a macrolide selected from the group consisting of tacrolimus, ascomycin, pimecrolimus, sirolimus, and everolimus from macrolide-containing biomatter, wherein the macrolide-containing biomatter is tacrolimus-containing biomatter when tacrolimus is to be obtained, ascomycin-containing biomatter when ascomycin is to be obtained, pimecrolimus-containing biomatter when pimecrolimus is to be obtained, sirolimus-containing biomatter when sirolimus is to be obtained, and everolimus-containing biomatter when everolimus is to be obtained, comprising the steps of:
- a) extracting macrolide-containing biomaffer that is whole fermentation broth obtained by fermentation of a microorganism selected from the group consisting of Streptomyces tsukubaensis, Streptomyces hygroscopicus, Streptomyces lividans, Streptomyces hygroscopicus hygroscopicus, and Streptomyces hygroscopicus ascomyceticus with a hydrophobic extraction solvent selected form the group consisting of n-butanol, iso-butanol, n-butyl acetate, iso-butyl acetate, t-butyl acetate, ethyl acetate, propyl acetate, ethyl formate, butyl methyl ketone, dichloromethane, chloroform, tetrachioromethane, dichloroethane and toluene to obtain a solution of macrolide in hydrophobic extraction solvent at a temperature between about 20° C. and about 70° C. and a pH of between 8 and about 13,
- b) separating the macrolide-containing solution from the extracted macrolide-containing biomatter,
- c) concentrating the macrolide-contaiing solution,
- d) loading the concentrated macrolide-containing solution onto a silica gel chromatography column and eluting the column with an eluent to obtain at least one macrolide-containing fraction that is a macrolide-containing solution, and
- e) separating the macrolide.
A method for obtaining a macrolide selected from the group consisting of tacrolimus, ascomycin, pimecrolimus, sirolimus, and everolimus from macrolide-containing biomatter, wherein the macrolide-containing biomatter is tacrolimus-containing biomatter when tacrolimus is to be obtained, ascomycin-containing biomatter when ascomycin is to be obtained, pimecrolimus-containing biomatter when pimecrolimus is to be obtained, sirolimus-containing biomatter when sirolimus is to be obtained, and everolimus-contaming biomafter when everolimus is to be obtained, the step of extracting macrolide-containing biomatter that is whole fermentation broth with a hydrophobic extraction solvent selected from the group consisting of n-butyl acetate, iso-butyl acetate, t-butyl acetate, ethyl acetate, propyl acetate, ethyl formate, butyl methyl ketone, dichioromethane, chloroform, tetrachloromethane, and toluene, wherein the pH of the macrolide-containing biomatter is between 8 and about 13 and recovering said macrolide from said solution.
A method of obtaining a macrolide selected from the group consisting of tacrolimus, ascomycin, pimecrolimus, sirolimus, and everolimus from macrolide-containing biomatter, wherein the macrolide-containing biomatter is tacrolimus-containing biomatter when tacrolimus is to be obtained, ascomycin-containing biomatter when ascomycin is to be obtained, pimecrolimus-containing biomafter when punecrolimus is to be obtained, sirolimus-containing biomatter when sirolimus is to be obtained, and everolimus-contaming biomaffer when everolimus is to be obtained, comprising the steps of:
- a) extracting a macrolide-containing biomaffer that is whole fermentation broth obtained by fermentation of a microorganism selected from the group consisting of Streptomyces tsukubaensis, Streptomyces hygroscopicus, Streptomyces lividans, Streptomyces hygroscopicus hygroscopicus, and Streptomyces hygroscopicus ascomyceticus, wherein the pH of the macrolide-containing biomaffer is between 8 and about 13, with iso-butyl acetate to obtain a solution of
- a macrolide in iso-butyl acetate at a temperature between about 2° C. and about 70° C.,
- b) separating the macrolide-containing solution from the extracted macrolide-containing biomatter, to obtain a concentrated macrolide-containing solution,
- c) concentrating the macrolide-containing solution,
- d) loading the concentrated macrolide-containing solution onto a silica gel chromatography column and eluting with an eluent to obtain at least one macrolide-containing fraction that is a macrolide-containing solution,
- e) concentrating at least one macrolide-containing fraction, and
- f) separating the macrolide.
Dependencies are inferred from the claim text.